Literature DB >> 28518081

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT.

Blake J Cochran1, William J Ryder2, Arvind Parmar3, Kerstin Klaeser4, Anthonin Reilhac5, Georgios I Angelis4, Steven R Meikle4, Philip J Barter6, Kerry-Anne Rye6.   

Abstract

This paper describes the use of 18F-FDG and micro-PET/CT imaging to determine in vivo glucose metabolism kinetics in mice (and is transferable to rats). Impaired uptake and metabolism of glucose in multiple organ systems due to insulin resistance is a hallmark of type 2 diabetes. The ability of this technique to extract an image-derived input function from the vena cava using an iterative deconvolution method eliminates the requirement of the collection of arterial blood samples. Fitting of tissue and vena cava time activity curves to a two-tissue, three compartment model permits the estimation of kinetic micro-parameters related to the 18F-FDG uptake from the plasma to the intracellular space, the rate of transport from intracellular space to plasma and the rate of 18F-FDG phosphorylation. This methodology allows for multiple measures of glucose uptake and metabolism kinetics in the context of longitudinal studies and also provides insights into the efficacy of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28518081      PMCID: PMC5565144          DOI: 10.3791/55184

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

1.  The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.

Authors:  K Kobayashi; T M Forte; S Taniguchi; B Y Ishida; K Oka; L Chan
Journal:  Metabolism       Date:  2000-01       Impact factor: 8.694

2.  Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.

Authors:  Carolina E Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Barbara C Fam; Henrik Ortsäter; Pierre Scotney; Daniel Nyqvist; Erik Samén; Li Lu; Sharon Stone-Elander; Joseph Proietto; Sofianos Andrikopoulos; Ake Sjöholm; Andrew Nash; Ulf Eriksson
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

3.  Simplified [18F]FDG image-derived input function using the left ventricle, liver, and one venous blood sample.

Authors:  Mohammed Noor Tantawy; Todd E Peterson
Journal:  Mol Imaging       Date:  2010-04       Impact factor: 4.488

4.  Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis.

Authors:  Caius G Radu; Chengyi J Shu; Stephanie M Shelly; Michael E Phelps; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-29       Impact factor: 11.205

5.  In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device.

Authors:  Hsiao-Ming Wu; Guodong Sui; Cheng-Chung Lee; Mayumi L Prins; Waldemar Ladno; Hong-Dun Lin; Amy S Yu; Michael E Phelps; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

6.  In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Shudi Tang; Anthonin Reilhac; Andrew Arthur; Arnaud Charil; Hasar Hamze; Philip J Barter; Leonard Kritharides; Steven R Meikle; Marie-Claude Gregoire; Kerry-Anne Rye
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

7.  Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method.

Authors:  Jussi Tohka; Anthonin Reilhac
Journal:  Neuroimage       Date:  2007-11-07       Impact factor: 6.556

8.  The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen.

Authors:  Judith E Flores; Leanne M McFarland; Alexander Vanderbilt; Annie K Ogasawara; Simon-Peter Williams
Journal:  Mol Imaging Biol       Date:  2008-05-31       Impact factor: 3.488

9.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

10.  Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly.

Authors:  Shiori Toba; Yasuhisa Tamura; Kanako Kumamoto; Masami Yamada; Keizo Takao; Satoko Hattori; Tsuyoshi Miyakawa; Yosky Kataoka; Mitsuyoshi Azuma; Kiyoshi Hayasaka; Masano Amamoto; Keiko Tominaga; Anthony Wynshaw-Boris; Hideki Wanibuchi; Yuichiro Oka; Makoto Sato; Mitsuhiro Kato; Shinji Hirotsune
Journal:  Sci Rep       Date:  2013-02-06       Impact factor: 4.379

View more
  2 in total

Review 1.  Blood-based bioenergetics: An emerging translational and clinical tool.

Authors:  Andrea Braganza; Gowtham K Annarapu; Sruti Shiva
Journal:  Mol Aspects Med       Date:  2019-12-18

Review 2.  Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia.

Authors:  Seok-Yeong Yu; Yi Luan; Rosemary Dong; Amirhossein Abazarikia; So-Youn Kim
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.